Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000635340> ?p ?o ?g. }
- W2000635340 endingPage "4776" @default.
- W2000635340 startingPage "4769" @default.
- W2000635340 abstract "Reactivation of hepatitis B virus (HBV) after rituximab-containing chemotherapy in patients with B-cell lymphoma has been recognized as a potentially serious complication in HBV immune patients.To determine the HBV reactivation in patients treated with rituximab, a retrospective study of HBV-related markers was performed before and after rituximab-containing treatment in 261 consecutive patients with CD20-positive B-cell lymphoma.Of the 261 patients, 230 patients were tested for both hepatitis B surface antigen (HBsAg) and antibody to hepatitis B core antigen (anti-HBc) before treatment. Fifty-six (24.3%) of 230 patients were anti-HBc positive, and the remaining 174 (75.6%) patients were anti-HBc negative. Among the 56 anti-HBc-positive patients, 5 (8.9%) became HBsAg positive (HBV reactivation), whereas none of the 174 anti-HBc-negative patients became HBsAg positive with a median follow-up of 24 months (P = .001). Among the 5 patients with HBV reactivation, 4 were negative for antibody to HBsAg (anti-HBs), and 1 patient was positive for anti-HBs. All 5 of these patients were treated successfully with entecavir on detection of HBsAg, although 4 of the 5 patients exhibited mild to moderate elevation of alanine aminotransferase. Among 56 anti-HBc-positive patients, those negative for anti-HBs had a higher probability of developing HBV reactivation compared with those positive for anti-HBs (4 of 19; 21.1% vs 1 of 37; 2.7%, P = .014).Patients with isolated anti-HBc are at high risk of HBV reactivation and should be monitored closely for HBsAg, anti-HBs, HBV-DNA, and transaminase levels during and after rituximab-containing treatment. Although preemptive use of entecavir enabled successful management of HBV reactivation, mild to moderate hepatic flare was still observed. These approaches should be further evaluated in a prospective study with regard to clinical usefulness, safety, and cost-effectiveness." @default.
- W2000635340 created "2016-06-24" @default.
- W2000635340 creator A5001310525 @default.
- W2000635340 creator A5010746455 @default.
- W2000635340 creator A5025340212 @default.
- W2000635340 creator A5038682298 @default.
- W2000635340 creator A5048725341 @default.
- W2000635340 creator A5056988797 @default.
- W2000635340 creator A5070277426 @default.
- W2000635340 date "2010-07-01" @default.
- W2000635340 modified "2023-09-25" @default.
- W2000635340 title "Reactivation of hepatitis B virus after rituximab-containing treatment in patients with CD20-positive B-cell lymphoma" @default.
- W2000635340 cites W1783838151 @default.
- W2000635340 cites W1972321006 @default.
- W2000635340 cites W1977520603 @default.
- W2000635340 cites W1990317890 @default.
- W2000635340 cites W1997047331 @default.
- W2000635340 cites W2008634850 @default.
- W2000635340 cites W2015806104 @default.
- W2000635340 cites W2019707844 @default.
- W2000635340 cites W2020511975 @default.
- W2000635340 cites W2025722002 @default.
- W2000635340 cites W2029301467 @default.
- W2000635340 cites W2031510386 @default.
- W2000635340 cites W2039004726 @default.
- W2000635340 cites W2047870060 @default.
- W2000635340 cites W2051055769 @default.
- W2000635340 cites W2058015212 @default.
- W2000635340 cites W2067642835 @default.
- W2000635340 cites W2077467565 @default.
- W2000635340 cites W2087510327 @default.
- W2000635340 cites W2102109062 @default.
- W2000635340 cites W2117964879 @default.
- W2000635340 cites W2119526388 @default.
- W2000635340 cites W2131922930 @default.
- W2000635340 cites W2133253108 @default.
- W2000635340 cites W2134997580 @default.
- W2000635340 cites W2138955583 @default.
- W2000635340 cites W2144016324 @default.
- W2000635340 cites W2153230421 @default.
- W2000635340 cites W2154643481 @default.
- W2000635340 cites W2161758234 @default.
- W2000635340 cites W2162326816 @default.
- W2000635340 cites W2162645287 @default.
- W2000635340 cites W4248716926 @default.
- W2000635340 cites W6940214 @default.
- W2000635340 doi "https://doi.org/10.1002/cncr.25253" @default.
- W2000635340 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20597091" @default.
- W2000635340 hasPublicationYear "2010" @default.
- W2000635340 type Work @default.
- W2000635340 sameAs 2000635340 @default.
- W2000635340 citedByCount "137" @default.
- W2000635340 countsByYear W20006353402012 @default.
- W2000635340 countsByYear W20006353402013 @default.
- W2000635340 countsByYear W20006353402014 @default.
- W2000635340 countsByYear W20006353402015 @default.
- W2000635340 countsByYear W20006353402016 @default.
- W2000635340 countsByYear W20006353402017 @default.
- W2000635340 countsByYear W20006353402018 @default.
- W2000635340 countsByYear W20006353402019 @default.
- W2000635340 countsByYear W20006353402020 @default.
- W2000635340 countsByYear W20006353402021 @default.
- W2000635340 countsByYear W20006353402022 @default.
- W2000635340 countsByYear W20006353402023 @default.
- W2000635340 crossrefType "journal-article" @default.
- W2000635340 hasAuthorship W2000635340A5001310525 @default.
- W2000635340 hasAuthorship W2000635340A5010746455 @default.
- W2000635340 hasAuthorship W2000635340A5025340212 @default.
- W2000635340 hasAuthorship W2000635340A5038682298 @default.
- W2000635340 hasAuthorship W2000635340A5048725341 @default.
- W2000635340 hasAuthorship W2000635340A5056988797 @default.
- W2000635340 hasAuthorship W2000635340A5070277426 @default.
- W2000635340 hasBestOaLocation W20006353401 @default.
- W2000635340 hasConcept C126322002 @default.
- W2000635340 hasConcept C147483822 @default.
- W2000635340 hasConcept C159654299 @default.
- W2000635340 hasConcept C18031839 @default.
- W2000635340 hasConcept C203014093 @default.
- W2000635340 hasConcept C2522874641 @default.
- W2000635340 hasConcept C2776175608 @default.
- W2000635340 hasConcept C2776694085 @default.
- W2000635340 hasConcept C2777382497 @default.
- W2000635340 hasConcept C2777410769 @default.
- W2000635340 hasConcept C2777869810 @default.
- W2000635340 hasConcept C2779338263 @default.
- W2000635340 hasConcept C2780593183 @default.
- W2000635340 hasConcept C2780653079 @default.
- W2000635340 hasConcept C71924100 @default.
- W2000635340 hasConcept C90924648 @default.
- W2000635340 hasConceptScore W2000635340C126322002 @default.
- W2000635340 hasConceptScore W2000635340C147483822 @default.
- W2000635340 hasConceptScore W2000635340C159654299 @default.
- W2000635340 hasConceptScore W2000635340C18031839 @default.
- W2000635340 hasConceptScore W2000635340C203014093 @default.
- W2000635340 hasConceptScore W2000635340C2522874641 @default.
- W2000635340 hasConceptScore W2000635340C2776175608 @default.
- W2000635340 hasConceptScore W2000635340C2776694085 @default.
- W2000635340 hasConceptScore W2000635340C2777382497 @default.